MARTHA SARINANA: Open Payments
NPI 1326417239 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 72 payments from 17 companies in 2025. Trend: 2023 $600 · 2024 $2,946 · 2025 $1,713
Food & beverage: $1,700Education: $13
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $355 |
| UROGEN PHARMA, INC. | 6 | $249 |
| Sumitomo Pharma America, Inc. | 15 | $181 |
| Ferring Pharmaceuticals Inc. | 5 | $165 |
| Olympus America Inc. | 7 | $159 |
| ABBVIE INC. | 8 | $141 |
| Boston Scientific Corporation | 2 | $126 |
| Teleflex LLC | 3 | $66 |
| IMMUNITYBIO, INC. | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $46 |
Products named: ERLEADA, JELMYTO, GEMTESA, ADSTILADRIN, iTIND System, BOTOX, RYBREVANT, Axonics.
Industry payments across TX — which companies pay providers there.
